Waning, Boosting and a Path to Endemicity for SARS-CoV-2

Matt J. Keeling, Amy Thomas, Edward M. Hill, Robin N. Thompson, Louise Dyson, Michael J. Tildesley, Sam Moore
doi: https://doi.org/10.1101/2021.11.05.21265977

Article Information

doi 
https://doi.org/10.1101/2021.11.05.21265977
History 
  • November 10, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Matt J. Keeling1,2,*,
  2. Amy Thomas2,3,
  3. Edward M. Hill1,2,
  4. Robin N. Thompson1,2,
  5. Louise Dyson1,2,
  6. Michael J. Tildesley1,2 and
  7. Sam Moore1
  1. 1Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, University of Warwick
  2. 2Joint University Pandemic Epidemiology Research (JUNIPER) Consortium
  3. 3Bristol Veterinary School, University of Bristol
  1. ↵* Corresponding author; email: m.j.keeling{at}warwick.ac.uk
Back to top
Posted November 10, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Waning, Boosting and a Path to Endemicity for SARS-CoV-2
Matt J. Keeling, Amy Thomas, Edward M. Hill, Robin N. Thompson, Louise Dyson, Michael J. Tildesley, Sam Moore
medRxiv 2021.11.05.21265977; doi: https://doi.org/10.1101/2021.11.05.21265977
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area